acuteadditionadenocarcinomaadjuvantadultsadvancedadversealkamlamonganalysisannualanotherarticleascoassessmentassociatedautologousbarriersbasedbetterbevacizumabbiologybiomarkerbiopsybrafbrainbrca1breastcancercancerscarcinomacardiaccarecellcetuximabchemoradiationchemotherapychildhoodchildrencoloncolorectalcombinationdatadecisiondetectiondiagnoseddiffusediscussiondiseasedondosedoubleearlyefficacyegfrendendometrialevolutionfinancialfirstfollicularfollowfollowinggastricgermlinehematopoieticher2highhithodgkinhormonehoursiiiimagingimmuneimpactimplicationsimportanceimproveimprovesinducedinhibitioninhibitorinsightsinvasivelargelateleukemialifelikelinelocallylonglowlunglymphoblasticlymphomalymphomasmaintenancemakemanagementmedicalmedicaremeetingmelanomametastasesmetastaticminimalmolecularmortalitymrdmultimultiplemutantmutatedmutationmutationsmyeloidmyelomanegativeneoadjuvantnivolumabnovelnsclcolderoptionsoutcomeoutcomesovarianpancreaticpatientpatientspediatricpembrolizumabphasepluspositiveprimaryprimeprognosticpromiseprostatequalityquestionradiationradiotherapyrarereadyreceivingreceptorrectalrecurrencerecurrentrefractoryrelapsedrelatedresearchresectableresidualresponseresultsriskrituximabrolesafetyscreeningsecondsequencingsettingsinglesmallsmokingstagestemstudysurgerysurvivalsurvivorssystemictermtestingtherapeutictherapytimetoxicitytransplanttransplantationtrastuzumabtreatedtreatmenttrialtrialstumortumorsuseusingvalueversuswomen